Winter Meeting of the Society of Urologic Oncology (SUO)suo

"Defining Excellence in Urologic Oncology"

December 2 - 4, 2015
Washington, DC USA

 

SUO 2015 Oncologic surveillance following radical cystectomy: an individualized risk-based approach - Poster Session Highlights

Washington, DC (UroToday.com) The optimal duration of surveillance for bladder cancer (BC) following radical cystectomy (RC) is unknown.

Read more ...

SUO 2015 The Current Status of Adjuvant Systemic Therapy for RCC - Session Highlights

Washington, DC (UroToday.com) In today’s Adjuvant therapy for localized renal cancer session at the 2015 Society of Urologic Oncology, Dr Uzzo Robert from Fox Chase Cancer center presented the difficulties in finding effective adjuvant therapy for RCC. Dr Uzzo called adjuvant treatment for RCC “the elusive holy grail of surgery” as it will hopefully bridge the gap between incompletely effective surgical therapy and completely effective systemic therapy. 

Read more ...

SUO 2015 Contemporary Utilization Trends and Survival Outcomes in Patients Undergoing Radical Cystectomy and Bladder Preservation Therapy for Muscle Invasive Bladder Cancer - Poster Session Highlights

Washington, DC (UroToday.com): David Cahn and the group from Einstein Healthcare Network and Fox Chase Cancer Center presented on the utilization trends and survival outcomes of patients undergoing radical cystectomy (RC) or bladder preservation therapy (BPT) using National Cancer Database (NCDB).

Read more ...

SUO 2015 Acute kidney injury after partial nephrectomy: the role of parenchymal mass reduction and ischemia and impact on subsequent functional recovery - Poster Session Highlights

Washington, DC (UroToday.com) In the SUO meeting poster session Zhiling Zhang and colleagues from the Cleveland Clinic presented their data on acute kidney injury after partial nephrectomy. Acute increase in serum creatinine (sCr) after partial nephrectomy (PN) is primarily due to parenchymal mass reduction or ischemia, however only ischemia can impact subsequent functional recovery. The authors evaluated etiologies of acute kidney injury (AKI) after PN and

Read more ...

SUO 2015 Resection Techniques for Nephron Sparing Surgery Vary: Analysis of a Prospectively Collected Multi-Institutional International Cohort Harnessing the Surface–Intermediate–Base (S.I.B.) Margin Score - Poster Session Highlights

Washington, DC (UroToday.com) In the SUO meeting poster session Alexander Kutikov and colleagues from the Fox Chase Cancer Center presented their data on partial nephrectomy resection techniques. Resection methodology during Nephron Sparing Surgery (NSS) is rarely reported. Yet, a relationship between technique and complication rates, preserved parenchymal volume, surgical margins, local recurrence, and oncologic outcomes likely exists. As such, the

Read more ...

SUO 2015 Endoscopic versus surgical management for patients with upper tract urothelial cancer as their first cancer diagnosis: A matched propensity score analysis using SEER-Medicare data - Poster Session Highlights

Washington, DC (UroToday.com) Radical nephroureterectomy with bladder cuff excision is the gold standard treatment for upper tract urothelial carcinoma (UTUC). For select patients, endoscopic management is another acceptable treatment option. In this study, Kim and colleagues from Washington University in St Louis sought to determine differences in OS and CSS between patients who receive endoscopic versus surgical management of UTUC. Using SEER-

Read more ...

SUO 2015 PARP Inhibitors and Prostate Cancer - Session Highlights

Washington, DC (UroToday.com) In today’s prostate cancer session at the 2015 Society of Urologic Oncology, Dr. Felix Feng from the University of Michigan presented his data og PARP inhibitors in prostate cancer treatment. It is known that 23% of CRPC harbor DNA repair alterations. Single DNA strand damage is repaired by the PARP protein. By inhibiting the protein the damage is not repaired but progresses to double strand damage. Since many cancers harbor DNA repair alterations (e.g. BRCA,

Read more ...